Questions about this study?
The HopeStage team will email you.
TerminatedNCT05181254
HEAlth Dialogues for Patients With Mental Illness in Primary Care
Behavioural studyAges 18+SwedenDepression
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Helsingborg, SwedenSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 1, 2020
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 167
- Sponsor
- Region Skane
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention
- Study phase
- Not clearly listed
- Locations
- Sweden
- Age range
- Over 18 Years
- Official registry ID
- NCT05181254
- Official title
Show the full official title
HEAlth Dialogues for Patients With Mental Illness in Primary Care
Recruitment & locations
TerminatedHelsingborg
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Region Skane.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
A randomized , double-blind, placebo-controlled study of antidepressant effects of the endogen compound neuropeptide y (NPY) in patients suffering from major depressive disorder
A Randomized, Double-blind, Placebo- and Active- controlled, Multicenter Study of Rapastinel as Monotherapy in Major Depressive Disorder